TI
Trexquant Investment Portfolio holdings
AUM
$8.86B
1-Year Return
23.46%
This Quarter Return
-2.71%
1 Year Return
+23.46%
3 Year Return
+83.97%
5 Year Return
+134.74%
10 Year Return
+204.61%
AUM
$2.84B
AUM Growth
+$612M
(+27%)
Cap. Flow
+$643M
Cap. Flow
% of AUM
22.62%
Top 10 Holdings %
Top 10 Hldgs %
10.64%
Holding
1,976
New
506
Increased
478
Reduced
320
Closed
670
Top Buys
| 1 |
Boeing
BA
|
+$34M |
| 2 |
S&P Global
SPGI
|
+$32.5M |
| 3 |
Adobe
ADBE
|
+$31M |
| 4 |
Phillips 66
PSX
|
+$20.9M |
| 5 |
Procter & Gamble
PG
|
+$20.8M |
Top Sells
| 1 |
Tesla
TSLA
|
+$25.1M |
| 2 |
PayPal
PYPL
|
+$16.7M |
| 3 |
AVLR
Avalara, Inc.
AVLR
|
+$15.9M |
| 4 |
Johnson & Johnson
JNJ
|
+$13.8M |
| 5 |
Idexx Laboratories
IDXX
|
+$13.8M |
Sector Composition
| 1 | Technology | 20.45% |
| 2 | Consumer Discretionary | 15.96% |
| 3 | Healthcare | 13.12% |
| 4 | Financials | 12.71% |
| 5 | Industrials | 11.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Renasant Corp
RNST
$3.7B
| $651K | 0.02% |
20,797
-51
| -0.2% | -$1.6K |
|
|
ACCD
702
DELISTED
Accolade, Inc. Common Stock
ACCD
| $651K | 0.02% |
+56,964
| New | +$651K |
|
703
AngloGold Ashanti
AU
$32.8B
| $644K | 0.02% |
46,623
-16,637
| -26% | -$230K |
|
704
Mersana Therapeutics
MRSN
$36.6M
| $642K | 0.02% |
+3,798
| New | +$642K |
|
705
Trex
TREX
$6.42B
| $642K | 0.02% |
14,608
-16,271
| -53% | -$715K |
|
706
Murphy Oil
MUR
$3.7B
| $640K | 0.02% |
+18,191
| New | +$640K |
|
707
Stoke Therapeutics
STOK
$1.21B
| $640K | 0.02% |
49,856
-33,801
| -40% | -$434K |
|
708
Ashland
ASH
$2.42B
| $636K | 0.02% |
+6,698
| New | +$636K |
|
709
DNOW Inc
DNOW
$1.61B
| $634K | 0.02% |
63,081
-28,701
| -31% | -$288K |
|
710
Medifast
MED
$152M
| $634K | 0.02% |
+5,851
| New | +$634K |
|
711
Veeva Systems
VEEV
$44.9B
| $634K | 0.02% |
+3,847
| New | +$634K |
|
712
Beazer Homes USA
BZH
$757M
| $633K | 0.02% |
65,494
+40,017
| +157% | +$387K |
|
713
Emergent Biosolutions
EBS
$421M
| $632K | 0.02% |
30,089
+14,412
| +92% | +$303K |
|
714
Flushing Financial
FFIC
$464M
| $632K | 0.02% |
32,614
+12,280
| +60% | +$238K |
|
|
AVTA
715
DELISTED
Avantax, Inc. Common Stock
AVTA
| $631K | 0.02% |
32,624
-12,503
| -28% | -$242K |
|
716
Open Text
OTEX
$8.9B
| $630K | 0.02% |
+23,830
| New | +$630K |
|
717
On Holding
ONON
$13.9B
| $627K | 0.02% |
+39,045
| New | +$627K |
|
718
TechTarget
TTGT
$400M
| $627K | 0.02% |
10,597
+6,048
| +133% | +$358K |
|
|
ISEE
719
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $626K | 0.02% |
34,878
-38,337
| -52% | -$688K |
|
720
Dolby
DLB
$6.8B
| $625K | 0.02% |
9,600
-5,800
| -38% | -$378K |
|
721
Ryan Specialty Holdings
RYAN
$6.49B
| $625K | 0.02% |
+15,397
| New | +$625K |
|
|
CTIC
722
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $624K | 0.02% |
107,192
-29,587
| -22% | -$172K |
|
723
ZipRecruiter
ZIP
$406M
| $623K | 0.02% |
37,740
-33,691
| -47% | -$556K |
|
724
UBS Group
UBS
$127B
| $621K | 0.02% |
42,784
-30,838
| -42% | -$448K |
|
725
Neurocrine Biosciences
NBIX
$14B
| $620K | 0.02% |
+5,836
| New | +$620K |
|